Overview
Chronic liver disease is the progressive, long-term deterioration of liver function arising from sustained injury, which drives inflammation, fibrosis, and ultimately cirrhosis with its attendant complications. Common causes include chronic viral hepatitis, alcohol-related and metabolic liver disease, and toxic injury, and the condition often advances silently before clinical decompensation. A central theme in this area is the epidemiology and clinical course of chronic liver disease, including retrospective hospital-based studies characterising its magnitude, trends, and patterns in different populations. A second strand concerns assessment and complications, including non-invasive measurement of liver stiffness and its relationship to decompensation and portal hypertension, and laboratory evaluation of associated disorders such as thrombocytopenia. A third addresses nutrition and protective factors, including vitamin D deficiency and its clinical significance in chronic liver disease, glycaemic considerations in liver-specific nutritional support, and the hepatoprotective effects of agents against oxidative and chemical injury. Related work examines liver cancer and outcomes in patients with coexisting conditions. Methodologically the field combines hospital cohorts, diagnostic studies, and experimental hepatoprotection models. By characterising the causes, progression, complications, and modifiable factors of chronic liver disease, research in this area informs earlier detection, risk stratification, and management aimed at slowing progression and improving outcomes.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Liver Stiffness by ARFI does not Correlate with Decompensation and Portal Hypertension in Patients with Cirrhosis
Evaluation of Vitamin D Deficiency in Patients with Chronic Liver Disease and Its Clinical Significance
Liver Disease: A Retrospective Hospital Based Study in Addis Ababa-Ethiopia
Stratified Analysis of Factors Associated With Mortality in Patients With COVID-19 Based on Cancer and Diabetes
Laboratory Tests Used in the Diagnosis of Immune Thrombocytopenia and General Treatment Approaches
Estimation of Glycemic Index of Liver Nutritional Supplement and its Importance in Liver Nutrition
The 5-HT1A Agonist Buspirone Decreases Liver Oxidative Stress and Exerts Protective Effect Against CCl4– Toxicity
Characterization of the Consciousness Energy Healing Treated Cholecalciferol Using LC-MS and GC-MS Spectrometry
Kynurenines and Vitamin B6: Link Between Diabetes and Depression.
Why People With Liver (or hepatic ) Cancer Should Die in Short - Time?
How this research is being cited
The 12 articles above have been cited 72 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · Naunyn-Schmiedeberg's Archives of Pharmacology
-
2026 · Scientific Reports
-
2026 · BioMed Research International
-
2026 · Naunyn-Schmiedeberg's Archives of Pharmacology
-
2025 · Toxicology and Applied Pharmacology
-
2025 · Naunyn-Schmiedeberg s Archives of Pharmacology
-
2025 · Pharmacological Research
-
2025 · Deleted Journal
A sample of recent works citing this journal's research on Chronic Liver Disease, linking to each citing work.